Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer

Japanese Journal of Clinical Oncology

Volumn 39, Issue 11, 2009, Pages 732-738

  Namiki, Shunichi ^a,b   Ishidoya, Shigeto ^a   Ito, Akihiro ^a   Tochigi, Tatsuo ^c   Numata, Isao ^b   Narazaki, Kakutaro ^a   Yamada, Shogo ^a   Takai, Yoshihiro ^a   Arai, Yoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaki City Hospital   (Japan)

^c Miyagi Cancer Center   (Japan)

Author keywords

Intensity modulated radiation therapy; Prostate cancer; Quality of life; Radiotherapy

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; SCORING SYSTEM; SEXUAL FUNCTION; SHORT FORM 36; UNIVERSITY OF CALIFORNIA LOS ANGELES PROSTATE CANCER INDEX;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CONFOUNDING FACTORS (EPIDEMIOLOGY); FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 70449419676     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp086     Document Type: Article

References (25)

1. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004;71:29-33.
2. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988;15:1299-305.
3. Pollack A, Zagars GK. External beam radiotherapy dose-response of prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:1011-18.
4. Smit WG, Helle PA, van Putten WL, Wijnmaalen AJ, Seldenrath JJ, van der Werf-Messing BH. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 1990;18:23-9.
5. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:876-81.
6. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-6.
7. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582-92.
8. Litwin MS, Fitzpatrick JM, Fossa SD, Newling DW. Defining an international research agenda for quality of life in men with prostate cancer. Prostate 1999;41:58-67.
9. Lips IM, van Gils CH, van der Heide UA, Kruger AE, van Vulpen M. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification. BJU Int 2009;103:762-7.
10. Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol 2006;36:224-30.
11. Yoshimura K, Kamoto T, Nakamura E, Segawa T, Kamba T, Takahashi T, et al. Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: Intensity-modulated radiation therapy versus conformal radiation therapy. Prostate Cancer Prostatic Dis 2007;10:288-92.
12. Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Matsushita H, Yamada S, et al. Development of a new linear accelerator mounted with dual fluoroscopy using amorphous silicon flat panel X-ray sensors to detect a gold seed in a tumor at real treatment position. Int J Radiat Oncol Biol Phys 2001;51:381.
13. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Yamada S. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med 2005;23:14-24.
14. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
15. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002-12.
16. Fukuhara S, Ware JE, Koshinski M. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol 1998;51:1045-53.
17. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, Suzukamo Y, et al. Development of Japanese version of the UCLA Prostate Cancer Index: A pilot validation study. Int J Clin Oncol 2002;7:306-11.
18. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. Changes in health-related quality of life in the first year after treatment for prostate cancer. Urology 1999;53:180-6.
19. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001;19:2517-26.
20. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multi-institutional outcomes study. J Clin Oncol 1997;15:223-9.
21. Breetvelt IS, Van Dam FS. Underreporting by cancer patients: The case of response-shift. Soc Sci Med 1991;32:981-7.
22. Mantz CA, Song P, Farhangi E, Nautiyal J, Awan A, Ignacio L, et al. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:551-7.
23. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Urology 1999;54:503-8.
24. Namiki S, Kwan L, Kagawa-Singer M, Saito S, Terai A, Satoh T, et al. Sexual function reported by Japanese and American men. J Urol 2008;179:245-9.
25. Namiki S, Saito S, Tochigi T, Ioritani N, Terai A, Arai Y. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy. Int J Urol 2007;14:186-91.